Velocity Clinical Research - Durham

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Obesity3 trials
• Familial hypercholesterolaemia1 trial

Phase

• Phase 21 trial
• Phase 31 trial
• Phase 41 trial

Status

• Active, not recruiting3 trials

Lead sponsor

• Amgen1 trial
• Currax Pharmaceuticals1 trial
• Regeneron Pharmaceuticals1 trial

Running trials

• Active, not recruiting

  A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

  NCT07477704· Phase 2· Regeneron Pharmaceuticals· Source

• Active, not recruiting

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· Phase 3· Amgen· Source

• Active, not recruiting

  Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)

  NCT06098079· Phase 4· Currax Pharmaceuticals· Source